SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-010902
Filing Date
2003-03-28
Accepted
2003-03-28 16:29:38
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2106664z10-k.htm 10-K 870947
3 EXHIBIT 4.23 a2106664zex-4_23.htm EX-4.23 130518
4 EXHIBIT 10.45 a2106664zex-10_45.htm EX-10.45 9524
5 EXHIBIT 10.46 a2106664zex-10_46.htm EX-10.46 57471
6 EXHIBIT 21.1 a2106664zex-21_1.htm EX-21.1 2744
7 EXHIBIT 23.1 a2106664zex-23_1.htm EX-23.1 2978
8 EXHIBIT 99.1 a2106664zex-99_1.htm EX-99.1 8353
  Complete submission text file 0001047469-03-010902.txt   1084935
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 03625647
SIC: 2834 Pharmaceutical Preparations